Protein-protein interactions: a structural view of inhibition strategies and the IL-23/IL-17 axis
Authors:
- 1 January 2020
- book chapter
- Published by Elsevier
- Vol. 121, 253-303
Abstract
No abstract availableKeywords
This publication has 195 references indexed in Scilit:
- Structural conservation of druggable hot spots in protein–protein interfacesProceedings of the National Academy of Sciences, 2011
- Small Molecule Inhibition of the TNF Family Cytokine CD40 Ligand through a Subunit Fracture MechanismACS Chemical Biology, 2011
- Interleukin-23 production in dendritic cells is negatively regulated by protein phosphatase 2AProceedings of the National Academy of Sciences, 2010
- Structural Basis for Acetylated Histone H4 Recognition by the Human BRD2 BromodomainJournal of Biological Chemistry, 2010
- Predicting druggable binding sites at the protein–protein interfaceDrug Discovery Today, 2009
- The Structure of Interleukin-23 Reveals the Molecular Basis of p40 Subunit Sharing with Interleukin-12Journal of Molecular Biology, 2008
- Protein–protein docking benchmark version 3.0Proteins: Structure, Function, and Bioinformatics, 2008
- Reaching for high-hanging fruit in drug discovery at protein–protein interfacesNature, 2007
- Small-molecule inhibitors of protein–protein interactions: progressing towards the dreamNature Reviews Drug Discovery, 2004
- Anatomy of protein pockets and cavities: Measurement of binding site geometry and implications for ligand designProtein Science, 1998